![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 52, Issue 6, 1113-1123, 1997
Laboratory of Molecular Neurobiology, Department of Pharmacology,
Boston University School of Medicine, Boston, Massachusetts 02118 (M.P.-C., F.-S.W., A.A.M., T.T.G., D.H.F.), and
Department of
Psychiatry, University of California School of Medicine, San Diego,
California 92161 (R.H.P.)
Steroid sulfation occurs in nervous tissue and endogenous sulfated
steroids can act as positive or negative modulators of N-methyl-D-aspartate (NMDA) receptor
function. In the current study, structure-activity relationships for
sulfated steroids were examined in voltage-clamped chick spinal cord
and rat hippocampal neurons in culture and in Xenopus
laevis oocytes expressing NR1100 and NR2A subunits.
The ability of pregnenolone sulfate (a positive modulator) and
epipregnanolone sulfate (a negative modulator) to compete with each
another, as well as with other known classes of NMDA receptor
modulators, was examined. The results show that steroid positive and
negative modulators act at specific, extracellularly directed sites
that are distinct from one another and from the spermine, redox,
glycine, Mg2+, MK-801, and arachidonic acid sites. Sulfated
steroids are effective as modulators of ongoing glutamate-mediated
synaptic transmission, which is consistent with their possible role as
endogenous neuromodulators in the CNS.
This article has been cited by other articles:
|
|
 |
|
  G. Sadri-Vakili, G. C. Janis, R. C. Pierce, T. T. Gibbs, and D. H. Farb Nanomolar Concentrations of Pregnenolone Sulfate Enhance Striatal Dopamine Overflow in Vivo J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 840 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Blanke and A. M. J. VanDongen The NR1 M3 Domain Mediates Allosteric Coupling in the N-Methyl-D-aspartate Receptor Mol. Pharmacol., August 1, 2008; 74(2): 454 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Grant, C. M. Helms, L. S. M. Rogers, and R. H. Purdy Neuroactive Steroid Stereospecificity of Ethanol-Like Discriminative Stimulus Effects in Monkeys J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 354 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mennerick, M. Lamberta, H.-J. Shu, J. Hogins, C. Wang, D. F. Covey, L. N. Eisenman, and C. F. Zorumski Effects on Membrane Capacitance of Steroids with Antagonist Properties at GABAA Receptors Biophys. J., July 1, 2008; 95(1): 176 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Johansson, P.-A. Frandberg, F. Nyberg, and P. Le Greves Molecular Mechanisms for Nanomolar Concentrations of Neurosteroids at NR1/NR2B Receptors J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 759 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kancheva, M. Hill, D. Cibula, H. Vcelakova, L. Kancheva, J. Vrbikova, T. Fait, A. Parizek, and L. Starka Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy J. Endocrinol., October 1, 2007; 195(1): 67 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Stoll, J. Hall, N. Van Buren, A. Hall, L. Knight, A. Morgan, S. Zuger, H. Van Deusen, and L. Gentile Differential Regulation of Ionotropic Glutamate Receptors Biophys. J., February 15, 2007; 92(4): 1343 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. El-Etr, Y. Akwa, E.-E. Baulieu, and M. Schumacher The Neuroactive Steroid Pregnenolone Sulfate Stimulates the Release of Gonadotropin-Releasing Hormone from GT1-7 Hypothalamic Neurons, through N-Methyl-D-Aspartate Receptors Endocrinology, June 1, 2006; 147(6): 2737 - 2743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Parizek, M. Hill, R. Kancheva, H. Havlikova, L. Kancheva, J. Cindr, A. Paskova, V. Pouzar, I. Cerny, P. Drbohlav, et al. Neuroactive Pregnanolone Isomers during Pregnancy J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 395 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-C. Chen, T.-J. Chang, and F.-S. Wu Competitive Inhibition of the Capsaicin Receptor-Mediated Current by Dehydroepiandrosterone in Rat Dorsal Root Ganglion Neurons J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 529 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-K. Jang, D. F. Mierke, S. J. Russek, and D. H. Farb A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity PNAS, May 25, 2004; 101(21): 8198 - 8203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Meyer, M. Carta, L. D. Partridge, D. F. Covey, and C. F. Valenzuela Neurosteroids Enhance Spontaneous Glutamate Release in Hippocampal Neurons. POSSIBLE ROLE OF METABOTROPIC sigma 1-LIKE RECEPTORS J. Biol. Chem., August 2, 2002; 277(32): 28725 - 28732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, Y. He, L. N. Eisenman, C. Fields, C.-M. Zeng, J. Mathews, A. Benz, T. Fu, E. Zorumski, J. H. Steinbach, et al. 3beta -Hydroxypregnane Steroids Are Pregnenolone Sulfate-Like GABAA Receptor Antagonists J. Neurosci., May 1, 2002; 22(9): 3366 - 3375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mennerick, C.-M. Zeng, A. Benz, W. Shen, Y. Izumi, A. S. Evers, D. F. Covey, and C. F. Zorumski Effects on gamma -Aminobutyric Acid (GABA)A Receptors of a Neuroactive Steroid That Negatively Modulates Glutamate Neurotransmission and Augments GABA Neurotransmission Mol. Pharmacol., October 1, 2001; 60(4): 732 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Paradiso, J. Zhang, and J. H. Steinbach The C Terminus of the Human Nicotinic {alpha}4{beta}2 Receptor Forms a Binding Site Required for Potentiation by an Estrogenic Steroid J. Neurosci., September 1, 2001; 21(17): 6561 - 6568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Engel, R. H. Purdy, and K. A. Grant Characterization of Discriminative Stimulus Effects of the Neuroactive Steroid Pregnanolone J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 489 - 495. [Abstract] [Full Text]
|
|
|
|
|
|
K. Paradiso, K. Sabey, A. S. Evers, C. F. Zorumski, D. F. Covey, and J. H. Steinbach Steroid Inhibition of Rat Neuronal Nicotinic alpha 4beta 2 Receptors Expressed in HEK 293 Cells Mol. Pharmacol., August 1, 2000; 58(2): 341 - 351. [Abstract] [Full Text]
|
|
|
|
|
|
C. E. Weaver, M. B. Land, R. H. Purdy, K. G. Richards, T. T. Gibbs, and D. H. Farb Geometry and Charge Determine Pharmacological Effects of Steroids on N-Methyl-D-aspartate Receptor-Induced Ca2+ Accumulation and Cell Death J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 747 - 754. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis The Glutamate Receptor Ion Channels Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Traynelis, M. F. Burgess, F. Zheng, P. Lyuboslavsky, and J. L. Powers Control of Voltage-Independent Zinc Inhibition of NMDA Receptors by the NR1 Subunit J. Neurosci., August 15, 1998; 18(16): 6163 - 6175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Costa, D. S. Olivera, D. A. Meyer, V. M. M. Ferreira, E. E. Soto, S. Frausto, D. D. Savage, M. D. Browning, and C. F. Valenzuela Fetal Alcohol Exposure Alters Neurosteroid Modulation of Hippocampal N-Methyl-D-aspartate Receptors J. Biol. Chem., December 1, 2000; 275(49): 38268 - 38274. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
